(Press-News.org) Antiviral Therapy Can Prevent Liver Cancer in Chronic Hepatitis B Patients
Bethesda, MD (June 23, 2014) — One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year. Two new studies appearing in the June issue of Gastroenterology provide strong evidence that antiviral therapy can reduce the risk of liver cancer in patients with chronic hepatitis B infection. Gastroenterology is the official journal of the American Gastroenterological Association.
In the first paper,1 researchers from National Yang-Ming University in Taiwan showed that the licensed oral antiviral agent nucleos(t)ide (NUC) resulted in a reduced long-term risk for liver cancer in a large, nationwide cohort of chronic hepatitis B patients. This retrospective study analyzed the risk of hepatocellular carcinoma, the most common form of liver cancer, in patients treated with several different agents. The NUC-treated cohort had a significantly lower seven-year incidence of liver cancer compared with controls. Overall, the effect of the treatment on reduced risk for cancer was stronger in young patients without cirrhosis and in patients without diabetes.
"Our findings suggest that NUC use reduces the risk of liver cancer in chronic hepatitis B patients, particularly in younger patients with minimal liver damage," said lead study author Chun-Ying Wu, MD, PhD. "The large cohort contributed to the strength of our study, leading to reliable results regarding who can benefit the most from this treatment."
The second study,2 also a retrospective analysis, compared outcomes of chronic hepatitis B patients treated with the antiviral agent entecavir and a less potent drug, lamivudine, at a tertiary care hospital in Seoul, Korea. Researchers found that patients in the entecavir group had a significantly lower risk of death or transplantation than patients treated with lamivudine; however this reduction in risk did not translate to a decreased risk of liver cancer. Both groups produced a similar reduction in liver cancer.
"There is a persistent risk of liver cancer in hepatitis B patients treated with even the most potent agents," said study author Young-Suk Lim, MD, PhD, from department of gastroenterology, University of Ulsan College of Medicine, Seoul, Korea. "Based on our findings, we support recommendations that surveillance for liver cancer should be continued in chronic hepatitis B patients regardless of the treatment used."
Both papers support the accumulating evidence that, to avert the risk of liver cancer, antiviral therapy needs to be initiated early during the chronic hepatitis B infection, preferably before the stage of advanced fibrosis.
INFORMATION:
For more information on hepatitis, read AGA's patient brochure.
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.
About Gastroenterology
Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, Current Awareness in Biological Sciences, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit http://www.gastrojournal.org.
Like AGA and Gastroenterology on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.
1 Wu, Chun-Ying et al. Association of Nucleos(t)ide Analogue Therapy with Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B – A Nationwide Cohort Study. Gastroenterology 2014: 148(8):143.
2 Lim, Young-Suk et al. Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Treated with Entecavir vs Lamivudine. Gastroenterology 2014: 148(8):152.
Antiviral therapy can prevent liver cancer in chronic hepatitis B patients
2014-06-23
ELSE PRESS RELEASES FROM THIS DATE:
Habitat loss, not poison, better explains grassland bird decline
2014-06-23
Contrary to recent well-publicized research, habitat loss, not insecticide use, continues to be the best explanation for the declines in grassland bird populations in the U.S. since the 1980s, according to a new study by ecologists.
Last year, a pair of researchers linked the drop in the populations of grassland bird species, such as the upland sandpiper and the Henslow's sparrow, to insecticide use, rather than to a rapid decline of grasslands, a more commonly accepted theory. However, after re-examining the data, Penn State and U.S. Department of Agriculture researchers ...
Hydrogel capsule, Gelesis100, reduces weight in overweight and obese subjects
2014-06-23
CHICAGO, IL — A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have similar diet and exercise instructions, an international multicenter study finds. The three-month results of the First Loss Of Weight (FLOW) study were presented Sunday June 22, 2014 at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
Gelesis100 (formerly Attiva) is an orally administered ...
Highlights from the June issue of GIE: Gastrointestinal Endoscopy
2014-06-23
DOWNERS GROVE, Ill. – June 23, 2014 – The June issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE), features a study reporting that the annual incidence rate of esophageal cancer among patients with Barrett's esophagus with low-grade dysplasia is 0.54 percent; a study showing that metabolic syndrome and smoking heighten concerns regarding colorectal cancer screening in men with these risk factors; and a new ASGE guideline on endoscopy in patients with lower gastrointestinal ...
Picture books for visually impaired kids go 3-D thanks to CU-Boulder research team
2014-06-23
"Goodnight room, goodnight moon. Goodnight cow jumping over the moon..."
A children's classic that already is a candidate for the all-time best feel-good book, "Goodnight Moon," has gotten a boost: A University of Colorado Boulder team printed the first 3D version of it, allowing visually impaired children and their families to touch objects in the story -- like the cow jumping over the moon -- as it is read aloud.
The story by Margaret Wise Brown of a bunny in bed wishing good night to his surroundings, "Goodnight Moon" was a logical first choice for CU-Boulder's Tactile ...
The JBEI GT Collection: A new resource for advanced biofuels research
2014-06-23
Researchers at the U.S. Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI) have unveiled the first glycosyltransferase clone collection specifically targeted for the study of the biosynthesis of plant cell walls. The idea behind what is being called "the JBEI GT Collection" is to provide a functional genomic resource for researchers seeking to extract the sugars in plant biomass and synthesize them into clean, green and renewable transportation fuels.
Glycosyltransferases (GTs) are enzymes that catalyze the connection of simple monosaccharide sugars into the ...
Growth hormone treatment for children may exacerbate feelings of depression
2014-06-23
CHICAGO, IL — Short, otherwise healthy children who are treated with growth hormone (GH) may become taller, but they may also become more depressed and withdrawn over time, compared to children the same age and height who are not treated with GH, a new study finds. The results were presented in a poster Monday, June 23 at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.
"Daily injections, frequent clinic visits and repeated discussions about height might exacerbate instead of improve psychosocial concerns ...
Sleeve gastrectomy surgery improves diabetes control better than medical care
2014-06-23
CHICAGO, IL — Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, a new study finds. The results were presented Monday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
In addition, 76 percent of surgery patients were able to reduce their use of diabetes medications, compared with only 26 percent of patients in the nonsurgical group, ...
All-star pitchers will hate instant replay, according to new research from Columbia Business School
2014-06-23
NEW YORK — It's a historic year for Major League Baseball, as the organization introduces its expanded use of instant replay, allowing umpires to review home run calls, forced plays, foul balls and more. But the one decision still left fully in the hands of umpires is the calling of the strike zone. Should the rules be expanded for review of those calls? A new study from Columbia Business School's professor Jerry Kim says reviewing strike zone calls may be the one call All-Stars pitchers would want reversed.
"Instant replay will become public enemy no. 1 for All-Star ...
Measuring the mass of 'massless' electrons
2014-06-23
Cambridge, Mass. – June 23, 2014 – Individual electrons in graphene are massless, but when they move together, it's a different story.
Graphene, a one-atom-thick carbon sheet, has taken the world of physics by storm—in part, because its electrons behave as massless particles. Yet these electrons seem to have dual personalities. Phenomena observed in the field of graphene plasmonics suggest that when the electrons move collectively, they must exhibit mass.
After two years of effort, researchers led by Donhee Ham, Gordon McKay Professor of Electrical Engineering and Applied ...
Nonsurgical treatment for enlarged prostate on the horizon
2014-06-23
You just cannot ignore your symptoms any longer. You find yourself getting up many times every night with the urgency to urinate. Saw palmetto, even high doses of the highest-quality type, didn't work.
A trip to the urologist results in bad news: a recommendation for surgery to treat your enlarged prostate (technically known as benign prostatic hyperplasia or BPH). A bit of Internet research on the proposed "transurethral resection of the prostate" makes you even more concerned – this surgery can result in sexual dysfunction and even impotence.
Aren't there non-invasive ...